Biofilm inhibitory effect of alginate lyases on mucoid P. aeruginosa from a cystic fibrosis patient

• Published in: Biochemistry and biophysics reports Vol. 26; p. 101028
• Main Authors: Mahajan, Sonal, Sunsunwal, Sonali, Gautam, Vikas, Singh, Meenu, Ramya, T.N.C.
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01.07.2021; Elsevier
• Subjects: Alginate lyase; Biofilm; Cellulophaga algicola; Cystic fibrosis; Mucoid; Pseudomonas aeruginosa; Short Communication; Sputum; Cellulophaga algicola; Sputum; Biofilm; Pseudomonas aeruginosa; Cystic fibrosis; Alginate lyase; Mucoid; CaAly
• ISSN: 2405-5808; 2405-5808
• DOI: 10.1016/j.bbrep.2021.101028

Chronic mucoid Pseudomonas aeruginosa infections are a major scourge in cystic fibrosis patients. Mucoid P. aeruginosa displays structured alginate-rich biofilms that are resistant to antibiotics. Here, we have assessed the efficacy of a panel of alginate lyases in combating mucoid P. aeruginosa biofilms in cystic fibrosis. Albeit we could not demonstrate alginate degradation by alginate lyases in sputum, we demonstrate that the endotypic alginate lyases, CaAly (from Cellulophaga algicola) and VspAlyVI (from Vibrio sp. QY101) and the exotypic alginate lyases, FspAlyFRB (from Falsirhodobacterium sp. alg1), and SA1-IV (from Sphingomonas sp. A1), indeed inhibit biofilm formation by a mucoid P. aeruginosa strain isolated from the sputum of a cystic fibrosis patient with comparative effect to that of the glycoside hydrolase PslG, a promising candidate for biofilm treatment. We believe that these enzymes should be explored for in vivo efficacy in future studies. •A P. aeruginosa strain was isolated from the sputum of a cystic fibrosis patient.•The anti-biofilm efficacy of endotypic and exotypic alginate lyases was assessed.•Alginate lyases CaAly, VspAlyVI, FspAlyFRB, and SA1-IV inhibited biofilm formation.•Similar anti-biofilm effect was observed for the glycoside hydrolase, PslG.